Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Synthace has raised $35.0M in total funding. The most recent round was Series C. The last funding was announced in November 2021.
Synthace's investors include Sofinnova Partners, Future Planet Capital, SOSV, Amadeus Capital Partners, 11.2 Capital.
Synthace is headquartered in London, United Kingdom.
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Synthace is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synthace — Funding & Investors." VCBacked, November 16, 2021, https://www.vcbacked.co/company/synthace. Accessed August 14, 2026.
VCBacked. (2021). Synthace — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/synthace
{{cite web |title=Synthace — Funding & Investors |url=https://www.vcbacked.co/company/synthace |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated